1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Atheroma

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Atheroma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berbée, JF; Habets, KL; Havekes, LM; Kooijman, S; Korporaal, SJ; Lammers, B; Meurs, I; Rensen, PC; Romijn, JA; van der Stoep, M; van Eck, M	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Atheroma

Article	Year
Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis. Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Aorta; Aortic Diseases; Atherosclerosis; Blood Platelets; Bone Marrow Transplantation; Diet, Western; Disease Models, Animal; Female; Genotype; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Inflammation; Inflammation Mediators; Leukocytes; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Platelet Activating Factor; Receptors, LDL; Time Factors	2015

Article

Year

Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.

Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13, Issue:1

Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Aorta; Aortic Diseases; Atherosclerosis; Blood Platelets; Bone Marrow Transplantation; Diet, Western; Disease Models, Animal; Female; Genotype; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Inflammation; Inflammation Mediators; Leukocytes; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Platelet Activating Factor; Receptors, LDL; Time Factors

2015